TransEnterix Announces US 510(k) FDA Clearance for Senhance Surgical Robotic System
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
TransEnterix (TRXC) PT Raised to $4.50 at Ladenburg Thalmann
October 17, 2017 11:10 AM EDTLadenburg Thalmann raised its price target on TransEnterix (NYSE: TRXC) to $4.50 (from $3.00) while maintaining a Buy rating.
Analyst Jeffrey Cohen made the change following FDA clearance,
... MoreTransEnterix (TRXC) Adds to Monday's Big Gains
October 17, 2017 9:54 AM EDTTransEnterix (NYSE: TRXC) adds to Monday gains following FDA 510(k) clearance for the Senhance Surgical Robotic System.
Shares are up 25.6% in early trading after gaining 93% Monday.
... More


